Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply. The ...
Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...
COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, announced today the successful ...
Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces ...
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore been ...
OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS’ CAR-T programs.
Beijing Zhongke Journal Publising Co. Ltd. This study is led by Professor Zhenghe Li (State Key Laboratory of Rice Biology and breeding, Institute of Biotechnology, Zhejiang University, Hangzhou, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results